# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-15-2024 | 03-31-2024 | 10-Q | |
2 | 02-14-2024 | 12-31-2023 | 10-Q | |
3 | 11-14-2023 | 09-30-2023 | 10-Q | |
4 | 09-28-2023 | 06-30-2023 | 10-K |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- SEC Filing
HC Wainwright & Co. analyst Yi Chen reiterates Renalytix (NASDAQ:RNLX) with a Buy and maintains $3 price target.